Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease [Carta] (2019)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.3324/haematol.2019.216788
- Subjects: PLAQUETAS SANGUÍNEAS; ANEMIA FALCIFORME; TRANSPLANTE HOMÓLOGO; CÉLULAS-TRONCO; FATORES ETÁRIOS; FATORES DE RISCO; NEUTRÓFILOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Haematologica
- ISSN: 0390-6078
- Volume/Número/Paginação/Ano: v. 104, n. 12, p. E543-E546, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CAPPELLI, Barbara et al. Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease [Carta]. Haematologica. Pavia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.3324/haematol.2019.216788. Acesso em: 02 fev. 2026. , 2019 -
APA
Cappelli, B., Volt, F., Tozatto-maio, K., Scigliuolo, G. M., Ferster, A., Dupont, S., et al. (2019). Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease [Carta]. Haematologica. Pavia: Faculdade de Medicina, Universidade de São Paulo. doi:10.3324/haematol.2019.216788 -
NLM
Cappelli B, Volt F, Tozatto-maio K, Scigliuolo GM, Ferster A, Dupont S, Simoes BP, Al-seraihy A, Aljurf MD, Rocha VG. Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease [Carta] [Internet]. Haematologica. 2019 ; 104( 12): E543-E546.[citado 2026 fev. 02 ] Available from: https://doi.org/10.3324/haematol.2019.216788 -
Vancouver
Cappelli B, Volt F, Tozatto-maio K, Scigliuolo GM, Ferster A, Dupont S, Simoes BP, Al-seraihy A, Aljurf MD, Rocha VG. Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease [Carta] [Internet]. Haematologica. 2019 ; 104( 12): E543-E546.[citado 2026 fev. 02 ] Available from: https://doi.org/10.3324/haematol.2019.216788 - Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
- Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
- Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases
- A novel mutation in RHAG causing Rh-null phenotype in Colombia. [Editorial]
- Comparative analysis of the variability of the human leukocyte antigen peptide-binding pockets in patients with acute leukaemia
- Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan
- Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
- Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era
- Validation of a formula predictive of peripheral blood stem cell yield and successful collection in healthy allogeneic donors
- Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin
Informações sobre o DOI: 10.3324/haematol.2019.216788 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
